Cargando…
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
Background: Immune checkpoint inhibitor hypophysitis (IIHs) is an emerging problem in cancer patients treated with immune checkpoint inhibitors (ICIs). We aimed to describe the clinical and molecular features of a multicenter series of IIHs. Methods: Demographic and clinical features were retrospect...
Autores principales: | Chiloiro, Sabrina, Giampietro, Antonella, Bianchi, Antonio, Menotti, Sara, Angelini, Flavia, Tartaglione, Tommaso, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Rossi, Ernesto, Schinzari, Giovanni, Scoppola, Alessandro, Pontecorvi, Alfredo, De Marinis, Laura, Fleseriu, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056499/ https://www.ncbi.nlm.nih.gov/pubmed/36983597 http://dx.doi.org/10.3390/jpm13030415 |
Ejemplares similares
-
THU093 Pituitary Enlargement And Hypopituitarism In Patients Treated With Immune Checkpoint Inhibitors: Two Sides Of The Same Coin?
por: Menotti, Sara, et al.
Publicado: (2023) -
Gastrointestinal carcinoma first presenting as pituitary mass: recognition of a rare case and multidisciplinary approach for the management of pituitary metastases
por: Costanza, Flavia, et al.
Publicado: (2023) -
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review
por: Menotti, Sara, et al.
Publicado: (2023) -
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case
por: Costanza, Flavia, et al.
Publicado: (2023) -
MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)